6533b7d1fe1ef96bd125d864
RESEARCH PRODUCT
Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease
L BatallerJ C MartinezA BalaguerTeresa SevillaE GómezHerminia Argente-escrigsubject
DystoniaPediatricsmedicine.medical_specialtybusiness.industryParkinsonismPrion diseaseDiseaseParkinsonismmedicine.disease030226 pharmacology & pharmacyCreutzfeldt-Jakob disease03 medical and health sciences0302 clinical medicineNeurologymedicineDementiaNeurology (clinical)businessLenalidomide030217 neurology & neurosurgerySubclinical infectionLenalidomidemedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Journal of the Neurological Sciences |